Thursday, February 5, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Breaking News

Applied Therapeutics Reports Disappointing Q4 Financial Results

Elaine Mendonca by Elaine Mendonca
March 6, 2024
in Breaking News
0
0
SHARES
10
VIEWS
Share on FacebookShare on Twitter

Applied Therapeutics (NASDAQ: APLT) unveiled its Q4 financial results on March 6, 2024, at 07:00 AM, revealing some important details:

– Earnings: The company fell short of expected earnings by -74.0%, with an EPS of $-0.4 compared to the projected $-0.23.
– Revenue: Revenue saw a decrease of $667 thousand from the same period in the previous year.
– Previous Performance: In the previous quarter, Applied Therapeutics missed EPS expectations by $0.21, resulting in a 2.0% decline in share price the following day.

For more insights and updates on Applied Therapeutics’ financial performance, investors can visit their investor relations page.

APLT Stock Performance on March 6, 2024: Trading in Middle of 52-Week Range

On March 6, 2024, APLT stock showed mixed performances as it traded in the middle of its 52-week range and above its 200-day simple moving average. The stock opened at $6.43, which was $0.26 higher than its previous close. However, throughout the trading day, the price of APLT shares decreased by $0.05, resulting in a 0.81% drop from the previous close.

APLT Stock Performance Analysis: Mixed Results on March 6, 2024

On March 6, 2024, APLT stock experienced mixed performances based on the available data from CNN Money. The company’s total revenue information was not available at the time, making it difficult to assess its overall financial health. However, looking at the net income and earnings per share figures, we can gain some insights into APLT’s recent performance.

APLT reported a net income of -$82.51 million over the past year, which represents a 21.86% increase compared to the previous year. However, the net income for the third quarter of the year was -$42.37 million, indicating a 43.25% decrease from the previous quarter. This significant decrease in net income from the previous quarter could be a cause for concern among investors.

Similarly, the earnings per share (EPS) figures for APLT also showed a mixed performance. The EPS for the past year was reported at -$2.18, marking a 47.12% increase from the previous year. However, the EPS for the third quarter of the year was -$0.47, reflecting a 24.88% decrease from the previous quarter. This decline in EPS from the previous quarter could indicate potential challenges for the company in maintaining profitability.

Overall, APLT stock performances on March 6, 2024, showed a mixed picture with an increase in net income and EPS compared to the previous year but a significant decrease from the previous quarter. Investors may need to closely monitor APLT’s financial performance and future earnings reports to assess the company’s long-term growth prospects and investment potential.

Tags: APLT
Elaine Mendonca

Elaine Mendonca

Related Posts

NFT projects
Breaking News

The Impact of TikToks Fate on USChina Relations and American Tech Giants

March 16, 2024
Businesses finance
Breaking News

Blackstone Strategic Credit 2027 Term Fund BGB Announces Monthly Dividend of 93 Cents per Share

March 15, 2024
Healthcare-sector
Breaking News

Analyzing Short Interest in Molina Healthcare Inc MOH

March 15, 2024
Next Post
Automotive Trading online

Challenges and Concerns for Nio Analysts Slash Price Targets

Finances-and-tech

Analysts Evaluation of Solo Brands Mixed Opinions and Price Targets

Ecommerce Stock Market Today

Title Appreciation for Detailed Postage Policy

Recommended

Gerresheimer Stock

Gerresheimer Shares Plunge Amid Deepening Crisis

4 months ago
Alphabet Stock

Regulatory Pressure Mounts on Alphabet as UK Designates Search Dominance

4 months ago
Technology Data analytics stock Trading (1)

Revolutionizing Ad Monetization Brightcove and Google Ad Manager Join Forces

2 years ago
MMP stock news

Yousif Capital Management Reduces Holdings in Alarm.com, Inc. – Analyzing Impact on Future Prospects

3 years ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Broadcom Coca-Cola Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials MSCI World ETF Newmont Mining NIO Novo Nordisk Nvidia Ocugen Opendoor Oracle Palantir PayPal Plug Power QuantumScape Robinhood Rocket Lab USA Strategy Super Micro Computer Synopsys Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics
No Result
View All Result

Highlights

Viking Therapeutics: Investors Await Key Clinical Updates in Forthcoming Report

Solana Faces Billions in Potential Token Supply Releases

CureVac Delisted Following BioNTech Acquisition Completion

Strategic Robotics Partnership Signals New Growth Phase for EOS Defence

NexPoint Residential Trust Sets Date for Annual and Q4 2025 Results

PC Connection Set to Report Full-Year and Fourth Quarter Earnings

Trending

CrowdStrike Stock
Analysis

CrowdStrike Shares Face Headwinds Amid Mixed Signals

by Andreas Sommer
February 5, 2026
0

The investment case for cybersecurity leader CrowdStrike is currently being shaped by conflicting developments. Positive legal news...

NCR Stock

NCR Voyix Charts a Course Toward Cloud-Centric Growth

February 5, 2026
Rolls Royce Stock

Rolls-Royce Shares: A Pivotal Period for Growth and Diversification

February 5, 2026
Viking Therapeutics Stock

Viking Therapeutics: Investors Await Key Clinical Updates in Forthcoming Report

February 5, 2026
Solana Stock

Solana Faces Billions in Potential Token Supply Releases

February 5, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • CrowdStrike Shares Face Headwinds Amid Mixed Signals
  • NCR Voyix Charts a Course Toward Cloud-Centric Growth
  • Rolls-Royce Shares: A Pivotal Period for Growth and Diversification

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com